BOLTBolt Biotherapeutics, Inc.

BOLT Stock Price, Valuation & Chart | Bolt Biotherapeutics, Inc.

Compare

$3.840-0.23 (-5.65%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology BOLT intrinsic value BOLT calculated fair value vs price

Overview Financials Dividends Ratios

BOLT Historical price chart

BOLT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization7.38M

PE Ratio-0.24

EPS-16.33

Trading Volume34.30K

Today's High/Low4.1/3.84

Dividend Yield0.00

52 Week High/Low7.2/3.13

Shares Outstanding1.92M

BOLT Financial Statement

BOLT Analyst ratings

BOLT Analysis & performance metrics

BOLT Company profile

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune…

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low…

BOLT Management team

Name

Position

Grant Yonehiro C.F.A., M.B.A.COO

Chief Operating Officer & Chief Business Officer

Nathan Ihle Ph.D.

Senior Vice President of Pharmaceutical Operations

William P. QuinnCEO

Chief Executive Officer, Chief Financial Officer, President, Secretary & Director

Sarah Nemec

Senior Vice President of Finance & Principal Accounting Officer

Wesley Burwell

Vice President & Head of Human Resources

Michael N. Alonso Ph.D.

Senior Vice President of Research

Name

Position

Grant Yonehiro C.F.A., M.B.A.COO

Chief Operating Officer & Chief Business Officer

Nathan Ihle Ph.D.

Senior Vice President of Pharmaceutical Operations

William P. QuinnCEO

Chief Executive Officer, Chief Financial Officer, President, Secretary & Director

Sarah Nemec

Senior Vice President of Finance & Principal Accounting Officer

Wesley Burwell

Vice President & Head of Human Resources

Michael N. Alonso Ph.D.

Senior Vice President of Research

Management Team

Grant Yonehiro C.F.A., M.B.A.COO

Chief Operating Officer & Chief Business Officer

Nathan Ihle Ph.D.

Senior Vice President of Pharmaceutical Operations

William P. QuinnCEO

Chief Executive Officer, Chief Financial Officer, President, Secretary & Director

Sarah Nemec

Senior Vice President of Finance & Principal Accounting Officer

Wesley Burwell

Vice President & Head of Human Resources

Michael N. Alonso Ph.D.

Senior Vice President of Research

Management

Grant Yonehiro C.F.A., M.B.A.COO

Chief Operating Officer & Chief Business Officer

Nathan Ihle Ph.D.

Senior Vice President of Pharmaceutical Operations

William P. QuinnCEO

Chief Executive Officer, Chief Financial Officer, President, Secretary & Director

Sarah Nemec

Senior Vice President of Finance & Principal Accounting Officer

Wesley Burwell

Vice President & Head of Human Resources

Michael N. Alonso Ph.D.

Senior Vice President of Research

Total 6 executives

BOLT Frequently asked questions

What is Bolt Biotherapeutics, Inc. (BOLT) Stock Price?

Current stock price of Bolt Biotherapeutics, Inc. (BOLT) stock is $3.840. The stock price is -5.65% lower in the session. The intraday range can be seen from this page. Volume of Bolt Biotherapeutics, Inc. (BOLT) stock is 34.30K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Bolt Biotherapeutics, Inc. (BOLT) stock price going up or down today?

The stock price of Bolt Biotherapeutics, Inc. (BOLT) can change with earnings, company news, and overall market sentiment. Bolt Biotherapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bolt Biotherapeutics, Inc. stock expensive at its current price?

Whether Bolt Biotherapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BOLT on this page is -0.24. EPS on this page is -16.33. Compare those figures with peers and growth expectations before deciding if the current Bolt Biotherapeutics, Inc. price is justified.

How has the stock price of Bolt Biotherapeutics, Inc. (BOLT) performed historically?

Historical performance for Bolt Biotherapeutics, Inc. (BOLT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BOLT reacted to past earnings and market events.

Should I buy Bolt Biotherapeutics, Inc. (BOLT) stock, at this price?

Buying Bolt Biotherapeutics, Inc. (BOLT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.